Clinical Trials
4
Active:0
Completed:2
Trial Phases
2 Phases
Phase 1:3
Phase 2:1
Drug Approvals
1
FDA:1
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 1
3 (75.0%)Phase 2
1 (25.0%)A Study to Evaluate the Ability of UB-612 COVID-19 Vaccine to Boost Immunity of Heterologous COVID-19 Vaccines.
Phase 1
Withdrawn
- Conditions
- COVID-19
- First Posted Date
- 2021-12-22
- Last Posted Date
- 2022-08-26
- Lead Sponsor
- United Biomedical Inc., Asia
- Registration Number
- NCT05167253
A Extension Study to Evaluate the Safety, Tolerability, and Immunogenicity of UB-612 COVID-19 Vaccine
Phase 1
Completed
- Conditions
- COVID-19
- First Posted Date
- 2021-07-20
- Last Posted Date
- 2022-08-26
- Lead Sponsor
- United Biomedical Inc., Asia
- Target Recruit Count
- 50
- Registration Number
- NCT04967742
- Locations
- 🇨🇳
China Medical University Hospital, Taichung, Taiwan
A Study to Evaluate UB-612 COVID-19 Vaccine in Adolescent, Younger and Elderly Adult Volunteers
Phase 2
Terminated
- Conditions
- COVID-19
- First Posted Date
- 2021-02-26
- Last Posted Date
- 2022-08-26
- Lead Sponsor
- United Biomedical Inc., Asia
- Target Recruit Count
- 3877
- Registration Number
- NCT04773067
- Locations
- 🇨🇳
Changhua Christian Hospital, Changhua, Taiwan
🇨🇳Chang-Geng Medical Foundation Kaoshiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan
🇨🇳Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Taiwan
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of UB-612 COVID-19 Vaccine
Phase 1
Completed
- Conditions
- COVID-19
- First Posted Date
- 2020-09-11
- Last Posted Date
- 2022-08-26
- Lead Sponsor
- United Biomedical Inc., Asia
- Target Recruit Count
- 60
- Registration Number
- NCT04545749
- Locations
- 🇨🇳
China Medical University Hospital, Taichung, Taiwan
News
No news found